Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BibbInstruments ABFRA:V0R +4.17%23 EBIT per Share is €-0.03 as of Mar. 2026. GuruFocus rates FRA:V0R with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 684 Medical Devices & Instruments companies, BibbInstruments AB ranks worse than 51.46% on this metric.
BibbInstruments AB's EBIT per Share for the
three
months ended in Mar. 2026 was €-0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.03.
During the past 3 years, the average EBIT per Share Growth Rate was 8.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 8.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for BibbInstruments AB's EBIT per Share or its related term are showing as below:
FRA:V0R'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -4.8 Med: 9.75 Max: 23.7
Current: 8.4
During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of BibbInstruments AB was 23.70% per year. The lowest was -4.80% per year. And the median was 9.75% per year.
FRA:V0R's 3-Year EBIT Growth Rate is ranked worse than 51.46% of 684
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs FRA:V0R: 8.40
BibbInstruments AB (FRA:V0R) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
BibbInstruments AB EBIT per Share Related Terms
BibbInstruments AB EBIT per Share Historical Data
* Premium members only.
The historical data trend for BibbInstruments AB's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BibbInstruments AB (FRA:V0R) has a EBIT per Share of €-0.03 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on BibbInstruments AB and its competitors. According to the industry distribution chart, BibbInstruments AB ranks #352 out of 684 companies in the Medical Devices & Instruments industry, placing it in the top 51.5%.
Is BibbInstruments AB's EBIT per Share too high?
BibbInstruments AB's current EBIT per Share is €-0.03. Based on the distribution chart, BibbInstruments AB ranks #352 out of 684 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, BibbInstruments AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does BibbInstruments AB's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BibbInstruments AB ranks #352 out of 684 companies for EBIT per Share. This places BibbInstruments AB in the lower half of its industry. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on BibbInstruments AB and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BibbInstruments AB's current EBIT per Share is €-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BibbInstruments AB stock overvalued right now?
BibbInstruments AB (FRA:V0R) has a current EBIT per Share of €-0.03. The current EBIT per Share is €-0.03. BibbInstruments AB's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For BibbInstruments AB (FRA:V0R), the current EBIT per Share is €-0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BibbInstruments AB develops disposable biopsy instrumentation under the brand EndoDrill for early detection of cancer tumors, especially in deep-tissue tumors. The product portfolio includes six disposable instruments based on the patented EndoDrill technology and a novel biopsy method still under development. The instruments will be used for tissue sampling (biopsy) of the most common types of cancer, for example; lung, breast, colorectal, prostate and stomach cancer.
23GF Score
Get the complete analysis for FRA:V0R
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:V0R has been successfully added to your 
